SCHEMBL5133161

SCHEMBL5133161

COCCN(C)c1ccc([N+](=O)[O-])cc1.O=[N+]([O-])c1ccc(Br)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
MMP14 P50281 1/20 0.45
CRHBP P24387 3/20 0.44
CRHR2 Q13324 3/20 0.44
POLB P06746 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP19A1 P11511 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 2/20 0.41
CYP1A2 P05177 1/20 0.41
TSHR P16473 1/20 0.41
PHLPP2 Q6ZVD8 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KCNH2 Q12809 3/20 0.40
ALDH1A1 P00352 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 2/20 0.39
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3033674 0.93 MAPT (0.64) MAPTMMP14CRHBPCRHR2POLB
SCHEMBL27512370 0.84 TAAR1 (0.39) MAPTMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL18660127 0.79 MAPT (0.77) MAPTMMP14CRHBPCRHR2POLB
SCHEMBL12006709 0.79 POLB (0.52) MAPTCRHBPCRHR2POLBMEN1
SCHEMBL20067707 0.76 MAPT (0.51) MAPTCRHBPCRHR2POLBMEN1
SCHEMBL18562081 0.76 BRAF (0.41) MAPTMEN1KMT2ATSHRALDH1A1
SCHEMBL18967271 0.76 MAOB (0.62) MAPT
SCHEMBL25355301 0.75 MAPT (0.50) MAPTCRHBPCRHR2POLBMEN1
SCHEMBL1728626 0.75 MAPT (0.70) MAPTMMP14CRHBPCRHR2POLB
SCHEMBL16706324 0.75 MAPT (0.81) MAPTMMP14CRHBPCRHR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008020203-A1 PYRIDINYLQUINAZ0LINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS ASTRAZENECA AB (SE) 2008-02-21 WO disclosed